P3 Long Term Safety Study of Once Daily SB204 in Acne
NCT02798120
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
601
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
SB204 4%
Sponsor
Novan, Inc.
Collaborators
[object Object]